HomeDNTH • NASDAQ
add
Dianthus Therapeutics Inc
Previous close
$18.75
Day range
$18.66 - $20.25
Year range
$13.37 - $32.27
Market cap
633.23M USD
Avg Volume
339.63K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 1.16M | 33.07% |
Operating expense | 34.34M | 83.46% |
Net income | -29.51M | -114.66% |
Net profit margin | -2.54K | -61.32% |
Earnings per share | -0.82 | — |
EBITDA | -33.15M | -86.01% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 263.23M | -30.18% |
Total assets | 348.58M | -8.86% |
Total liabilities | 19.97M | 104.34% |
Total equity | 328.61M | — |
Shares outstanding | 32.16M | — |
Price to book | 1.83 | — |
Return on assets | -22.96% | — |
Return on capital | -24.25% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -29.51M | -114.66% |
Cash from operations | -27.63M | -84.93% |
Cash from investing | 14.79M | 368.64% |
Cash from financing | 161.00K | -99.93% |
Net change in cash | -12.68M | -106.42% |
Free cash flow | -18.82M | -91.01% |
About
Founded
2019
Website
Employees
78
